Skip to main content

Find Clinical Trials

Home
Conditions
Hyperlipoproteinemias

Clinical trial condition

Hyperlipoproteinemias

Explore clinical trials studying Hyperlipoproteinemias. Study availability and eligibility vary by location and protocol.

231 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Hyperlipoproteinemias trial results

Completed

Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment

NCT02585895

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Research Site Boca Raton, Florida, United States

Research Site Kansas City, Kansas, United States

Research Site Grandville, Michigan, United States

Research Site Portland, Oregon, United States

View all 17 locations

View Trial Details

Completed

Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study

NCT01375751

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Not specified

View Trial Details

Completed

Return of Actionable Variants Empirical Study

NCT03640234

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations: Not specified

View Trial Details

Completed

Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI

NCT03795038

Conditions: Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +10 more
Locations: Nephrocare Rostock GmbH Rostock, Mecklenburg-Vorpommern, Germany

Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Dresden, Saxony, Germany

View Trial Details

Completed

Alirocumab and Plaque Burden In Familial Hypercholesterolaemia

NCT05465278

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations: Fundacion Hipercolesterolemia Familiar Madrid, Spain

View Trial Details

Completed

Effects of a Workplace Exercise Intervention on Cardio-Metabolic Health

NCT04403789

Conditions: Behavior, Cardiovascular Diseases, Cardiovascular Risk Factor, +20 more
Locations: Emirates Integrated Telecommunication Company (Du), Headquarters Building. Dubai, Dubai Internet City, United Arab Emirates

View Trial Details

Completed

A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)

NCT00705211

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +11 more
Locations: Not specified

View Trial Details

Completed

A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)

NCT00704444

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +11 more
Locations: Not specified

View Trial Details

Completed

Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)(COMPLETED)

NCT00704535

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Not specified

View Trial Details

Completed

Vytorin Reexamination Study (0653A-174)

NCT01070966

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +15 more
Locations: Not specified

View Trial Details